Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 5, 2012, Pages 1078-1085

  Lin, Steven H ^a   Wang, Lu ^b   Myles, Bevan ^a   Thall, Peter F ^a   Hofstetter, Wayne L ^a   Swisher, Stephen G ^a   Ajani, Jaffer A ^a   Cox, James D ^a   Komaki, Ritsuko ^a   Liao, Zhongxing ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2-GROUP; 3-DIMENSIONAL; CARDIAC DEATH; CLINICAL OUTCOME; CONFORMAL RADIOTHERAPY; COVARIATES; COX MODEL; CUMULATIVE INCIDENCE; DISTANT METASTASIS; DOSE CONFORMALITY; ESOPHAGEAL CANCER; HAZARD RATIO; INTENSITY-MODULATED RADIOTHERAPY; LOCAL FAILURE; LOCOREGIONAL CONTROL; LOCOREGIONAL RECURRENCE; LOGISTIC REGRESSION ANALYSIS; LONG-TERM OUTCOME; NORMAL TISSUE; OVERALL SURVIVAL; PROGNOSTIC FACTORS; PROPENSITY SCORE; RADIATION EXPOSURE; TREATMENT MODALITY;

CARDIAC RESYNCHRONIZATION THERAPY; CHEMORADIOTHERAPY; DISEASES; PATHOLOGY; PHYSICAL THERAPY; PROBABILITY; RADIOTHERAPY; REGRESSION ANALYSIS; THREE DIMENSIONAL COMPUTER GRAPHICS; TISSUE;

THREE DIMENSIONAL;

FLUOROURACIL; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISTANT METASTASIS; DOSIMETRY; DRUG FATALITY; ESOPHAGUS CANCER; FEMALE; HEART DEATH; HUMAN; HYPOTHESIS; INTENSITY MODULATED RADIATION THERAPY; LOG RANK TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROBABILITY; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE; THREE DIMENSIONAL CONFORMAL RADIOTHERAPY; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CAUSE OF DEATH; CHEMORADIOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; STANDARD OF CARE;

EID: 84869139020     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.02.015     Document Type: Article

References (20)

1. ACS. Esophageal Cancer. Available at: www.cancer.org/Cancer/ EsophagusCancer/DetailedGuide/esophagus-cancer-key-statistics. 2012 Cancer Statistics. Accessed February 6, 2012.
2. L. Fenkell, I. Kaminsky, and S. Breen Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus Radiother Oncol 89 2008 287 291
3. A. Chandra, T.M. Guerrero, and H.H. Liu Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer Radiother Oncol 77 2005 247 253
4. C.M. Nutting, J.L. Bedford, and V.P. Cosgrove A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy Radiother Oncol 61 2001 157 163
5. V.W.C. Wu, D.L.W. Kwong, and J.S.T. Sham Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy Radiother Oncol 71 2004 201 206
6. V.W.C. Wu, J.S.T. Sham, and D.L.W. Kwong Inverse planning in three-dimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer Br J Radiol 77 2004 568 572
7. J.M. Robins, M.A. Hernán, and B. Brumback Marginal structural models and causal inference in epidemiology Epidemiology 11 2000 550 560
8. M. Sugihara Survival analysis using inverse probability of treatment weighted methods based on the generalized propensity score Pharm Stat 9 2009 21 34
9. T.M. Therneau, P.M. Grambsch, and T.R. Fleming Martingale-based residuals for survival models Biometrika 77 1990 147 160
10. P.M. Grambsch, and T.M. Therneau Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 1994 515 526
11. R.B. D'Agostino Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265 2281
12. J.F. Boivin, G.B. Hutchison, and J.H. Lubin Coronary artery disease mortality in patients treated for Hodgkin's disease Cancer 69 1992 1241 1247
13. J.M. Cosset, M. Henry-Amar, and B. Pellae-Cosset Pericarditis and myocardial infarctions after Hodgkin's disease therapy Int J Radiat Oncol Biol Phys 21 1991 447 449
14. H. Joensuu Acute myocardial infarction after heart irradiation in young patients with Hodgkin's disease Chest 95 1989 388 390
15. B.D. Minsky, T.F. Pajak, and R.J. Ginsberg INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy J Clin Oncol 20 2002 1167 1174
16. S. Ishikura, K. Nihei, and A. Ohtsu Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus J Clin Oncol 21 2003 2697 2702
17. M. Morota, K. Gomi, and T. Kozuka Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma Int J Radiat Oncol Biol Phys 75 2009 122 128
18. T.H. La, A.Y. Minn, and Z. Su Multimodality treatment with intensity modulated radiation therapy for esophageal cancer Dis Esophagus 23 2010 300 308
19. T. Takahashi, H. Ishikawa, and T. Ebara The role of intensity modulated radiotherapy (IMRT) for locally advanced esophageal cancer Jap J Clin Radiol 55 2010 1114 1120
20. X.D. Lin, X.Y. Shi, and T.C. Zhou Intensity-modulated or 3-D conformal radiotherapy combined with chemotherapy with docetaxel and cisplatin for locally advanced esophageal carcinoma Nan Fang Yi Ke Da Xue Xue Bao 31 2011 1264 1267